Jan Dörr Selected Research

Susac Syndrome

12/2016	Diagnostic criteria for Susac syndrome.
2/2016	RETINAL LESION EVOLUTION IN SUSAC SYNDROME.
8/2015	Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography.
1/2014	Update on Susac syndrome: new insights in brain and retinal imaging and treatment options.
1/2014	Susac syndrome treated with subcutaneous immunoglobulin.
1/2014	Optical coherence tomography for retinal imaging in multiple sclerosis.
6/2013	Characteristics of Susac syndrome: a review of all reported cases.
1/2012	Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Dörr Research Topics

Disease

31	Multiple Sclerosis 01/2021 - 02/2002
10	Relapsing-Remitting Multiple Sclerosis 01/2021 - 04/2008
8	Susac Syndrome 12/2016 - 01/2012
4	Atrophy 01/2021 - 10/2010
4	Ganglion Cysts (Ganglion) 01/2021 - 08/2015
3	Optic Neuritis (Retrobulbar Neuritis) 03/2020 - 10/2010
3	Retinal Artery Occlusion 02/2016 - 06/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 02/2002
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 09/2013
2	Inflammation (Inflammations) 01/2016 - 09/2013
2	Hearing Loss (Hearing Impairment) 01/2014 - 06/2013
1	Vitamin D Deficiency 01/2020
1	Fatigue 01/2018
1	Vascular Diseases (Vascular Disease) 02/2016
1	Cicatrix (Scar) 08/2015
1	Brain Diseases (Brain Disorder) 01/2014
1	Neuromyelitis Optica (Devic's Disease) 01/2014
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 09/2013
1	Friedreich Ataxia (Friedreich's Ataxia) 09/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2013
1	Scotoma (Scintillating Scotoma) 06/2012
1	Chronic Progressive Multiple Sclerosis 01/2012
1	Glaucoma 10/2010
1	Heart Failure 03/2010
1	Encephalomyelitis (Myeloencephalitis) 12/2009
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 12/2009
1	Neuroinflammatory Diseases 10/2005
1	Glioma (Gliomas) 01/2002

Drug/Important Bio-Agent (IBA)

15	Retinaldehyde (Retinal)IBA 01/2021 - 12/2009
4	Vitamin D FDA LinkGeneric 01/2020 - 02/2012
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021 - 01/2021
3	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2012 - 03/2010
2	Polysaccharides (Glycans)IBA 01/2021 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 03/2020
2	Cholecalciferol (Vitamin D3)FDA Link 01/2020 - 02/2012
2	hydroxide ionIBA 01/2020 - 01/2016
2	flupirtineIBA 01/2018 - 10/2005
2	maleic acid (maleate)IBA 01/2018 - 10/2005
2	25-hydroxyvitamin DIBA 01/2016 - 02/2012
2	AntigensIBA 06/2013 - 01/2002
1	Glatiramer Acetate (Copaxone)FDA Link 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	AcetylglucosamineIBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2018
1	Interferon beta-1b (Betaseron)FDA Link 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	FrankincenseIBA 01/2018
1	gadobutrolIBA 06/2017
1	Alemtuzumab (Campath)FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 03/2014
1	GlucocorticoidsIBA 01/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2014
1	AntioxidantsIBA 09/2013
1	idebenoneIBA 09/2013
1	A 7 (A-7)IBA 03/2013
1	CalciumIBA 01/2013
1	Therapeutic UsesIBA 02/2012
1	N-acetylaspartate (N-acetyl aspartate)IBA 04/2011
1	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 10/2010
1	Methylprednisolone FDA LinkGeneric 12/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2009
1	Atorvastatin (Lipitor)FDA Link 04/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008
1	Death Domain ReceptorsIBA 02/2002
1	LigandsIBA 02/2002
1	Fas Ligand Protein (Fas Ligand)IBA 01/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2010
1	Transcranial Magnetic Stimulation 01/2018
1	Oral Administration 01/2018
1	Treatment Delay 12/2016
1	Stem Cell Transplantation 08/2016